药学英语药学英语 (26).pptVIP

Unit Nine Nonclinical Development of Biopharmaceuticals 生物药物 Part five Safety risks are generally directly related to uncertainty and are reduced through knowledge and best scientific practices. However, because of the heterogeneity of this compound class and the different approaches needed for different types of biologics, our future nonclinical development programs (NDPs) must be considered largely on a case-by-case basis. 安全风险一般直接与不确定性有关，可通过认知的提高和适合的科学实践来降低。 然而由于这一类化合物的不均一性以及不同类型的生物制品需要不同的方法，我们必须根据具体情况来考虑未来的非临床研究。 Study Design and Types of Nonclinical Safety